Stock Events

Recordati SpA 

$50
79
+$0+0% Tuesday 20:00

Statistics

Day High
51.6
Day Low
51.6
52W High
51.98
52W Low
46
Volume
1,459
Avg. Volume
0
Mkt Cap
10.79B
P/E Ratio
0
Dividend Yield
2.62%
Dividend
1.31

Upcoming

Dividends

2.62%Dividend Yield
10Y Growth
14.34%
5Y Growth
4.32%
3Y Growth
1.05%
1Y Growth
2.8%

Earnings

8MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
0.34
0.46
0.57
0.69
Expected EPS
0.69
Actual EPS
0.59

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RCDTF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap232.42B
Novartis is a global healthcare company that competes with Recordati in the pharmaceuticals sector, particularly in the development and marketing of prescription medications.
Pfizer
PFE
Mkt Cap169.83B
Pfizer is a large pharmaceutical company that competes directly with Recordati in the development and distribution of drugs across various therapeutic areas.
Merck &
MRK
Mkt Cap318.55B
Merck & Co. is a leading pharmaceutical company that competes with Recordati in the research, development, and marketing of drugs, especially in the areas of cardiovascular diseases.
Abbvie
ABBV
Mkt Cap304.29B
AbbVie competes with Recordati in the pharmaceutical industry, particularly in the development of therapies for diseases in areas like immunology and oncology, which may overlap with Recordati's product offerings.
GSK
GSK
Mkt Cap81.55B
GlaxoSmithKline is a global healthcare company that competes with Recordati in the pharmaceutical and healthcare sector, including the development of medications for various diseases.
Astrazeneca
AZN
Mkt Cap244.04B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company that competes with Recordati in the development and marketing of prescription medicines, particularly in the cardiovascular, renal, and metabolism therapeutic areas.
Sanofi
SNY
Mkt Cap128.21B
Sanofi is a global healthcare leader that competes with Recordati in the pharmaceutical sector, offering a wide range of prescription medicines, vaccines, and over-the-counter healthcare products.
Bristol-Myers Squibb
BMY
Mkt Cap86.44B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Recordati in the discovery, development, and delivery of medicines in areas such as cardiovascular, oncology, and immunoscience.
Johnson & Johnson
JNJ
Mkt Cap372.29B
Johnson & Johnson is a diversified healthcare giant that competes with Recordati not only in the pharmaceutical sector but also in consumer health products and medical devices.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap19.04B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing with Recordati in the generic drug market and in the development of specialty pharmaceuticals.

About

Pharmaceuticals: Major
Health Technology
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.
Show more...
CEO
Andrea Recordati
Employees
4455
Country
IT
ISIN
IT0003828271
WKN
000A0EABR

Listings